Impower110: Interim OS Analysis of a Phase III Study Of Atezolizumab (ATEZO) vs Platinum-Based Chemotherapy (Chemo) as 1L Treatment (TX) in PD-L1-Selected NSCLC

Reinmuth, Niels; ...; Andric, Zoran G; ...; (broj, koautora 20)

Results

eNauka > Results > Impower110: Interim OS Analysis of a Phase III Study Of Atezolizumab (ATEZO) vs Platinum-Based Chemotherapy (Chemo) as 1L Treatment (TX) in PD-L1-Selected NSCLC

Title:	Impower110: Interim OS Analysis of a Phase III Study Of Atezolizumab (ATEZO) vs Platinum-Based Chemotherapy (Chemo) as 1L Treatment (TX) in PD-L1-Selected NSCLC
Authors:	Reinmuth, Niels; ...; Andric, Zoran G ; ...; (broj, koautora 20)
Issue Date:	2020
Publication:	ONCOLOGY RESEARCH AND TREATMENT
ISSN:	2296-5270 Oncology Research and Treatment Search Idenfier
Type:	Conference Paper
Collation:	vol. 43 str. 232-233
WoS-ID:	000517158700578
URI:	https://enauka.gov.rs/handle/123456789/821501
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM